Predictive Immunoinformatics Reveal Promising Safety and Anti-Onchocerciasis Protective Immune Response Profiles to Vaccine Candidates (Ov-RAL-2 and Ov-103) in Anticipation of Phase I Clinical Trials
Preprint in bioRxiv (May 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Preprint in bioRxiv (May 2024)